Although stem cell therapy is fairly new to veterinary medicine, it has been demonstrated to be an effective treatment in numerous animal
models of disease such as osteoarthritis, tendon repair, fractures, muscular dystrophy, autoimmune problems, and other disorders.
Duke s research will use patented multielectrode technology to directly measure the activity of hundreds of neurons to study brain dynamics in unique preclinical
models of diseases such as Parkinson s and schizophrenia.
Not exact matches
Although the observational studies that underlie our
models all adjusted for multiple confounders, including known risk factors for the
disease outcomes
of interest, risk factors for early breastfeeding cessation
such as preterm birth, preeclampsia, and obesity are also risk factors for metabolic
disease in later life.
We do not cover developments
of interest only to specialists,
such as new animal
models of a
disease or the opening
of new science research centres.
The behavioral tests used here
modeled one dimension
of the
disease — an inability to experience pleasure from normal activities — but not others,
such as stress and anxiety, and probably tap into different brain mechanisms in mice than in humans, he says.
Currently, I work on three directions: (1) cell motility and the cytoskeleton, (2)
modeling of physiology and
diseases (
such as autoimmune diabetes), and (3) swarming and aggregation behaviour in social organisms.
But epidemiologists are increasingly turning to agent - based
models to include factors that the equations ignore,
such as geography, transportation networks, family structure, and behavior change — all
of which can strongly affect how
disease spreads.
He says they hope to be able to create miniature
models of brains experiencing a range
of diseases,
such as Parkinson's and Alzheimer's.
Satellite imagery is used for all sorts
of climate study, from identifying conditions that allow infectious
diseases like West Nile virus and cholera to emerge, to creating
models for predicting hurricanes, to distinguishing natural resources
such as wind, water and sunlight.
The new research investigated the effectiveness
of MSC therapy in a mouse
model of chronic inflammatory lung
disease, which reflects some
of the essential features
of diseases such as COPD and cystic fibrosis.
These techniques include: human tissue created by reprogramming cells from people with the relevant
disease (dubbed «patient in a dish»); «body on a chip» devices, where human tissue samples on a silicon chip are linked by a circulating blood substitute; many computer
modelling approaches,
such as virtual organs, virtual patients and virtual clinical trials; and microdosing studies, where tiny doses
of drugs given to volunteers allow scientists to study their metabolism in humans, safely and with unsurpassed accuracy.
Modern geographers and cartographers are involved in diverse projects: tracking fleets
of vehicles or products, helping customers locate a Dunkin' Donuts,
modeling environmental scenarios
such as oil spills, and studying the spread
of disease.
Some studies blame a parasite - stress
model: High infectious
disease rates can exacerbate tensions
such as xenophobia and strain resources, elevating the risk
of conflict.
Flaherty, who studies conditions
such as hypergraphia (an uncontrollable urge to write) and writer's block, also looks to
disease models to explain the drive behind this mode
of communication.
He hopes the
model will be useful for future predictions along these lines,
such as looking at pathways
of disease progression.
Researchers at RTI International will continue to further refine their
model to incorporate other national health issues,
such as obesity, and to also assess how positive interventions could alter the course
of kidney
disease in America.
A new Journal
of Internal Medicine article proposes that artificial intelligence tools,
such as machine learning algorithms, have the potential for building predictive
models for the diagnosis and treatment
of diseases linked to imbalances in gut microbial communities, or microbiota.
The new Penn - developed
model replaces a previous
model that only examined pre-operative features
such as a history
of chronic obstructive pulmonary
disease, congestive heart failure, or coronary artery
disease.
The most important advancement in medicine in the last 25 years was the development
of genetic
modeling in animals, enabling us to figure out how fundamental mechanisms
of physiology and
disease work,
such as in bone loss.
«Additionally, the genetically - engineered mouse
model will allow us to test potential treatments aimed at correcting achlorhydria, not just for gastric NETS, but also for other
diseases of the gastrointestinal system
such as Barrett's esophagus (chronic inflammation
of the lower part
of the esophagus), or hiatus hernia,» says Dr Calvete.
Potential outbreaks
of diseases such as Ebola and Lassa fever may be more accurately predicted thanks to a new mathematical
model developed by researchers at the University
of Cambridge.
Such ease
of use will likely encourage the use
of more animal
models in the study
of human
diseases, says Rhonda Wiler, a geneticist at biotech giant Genentech in San Francisco, California, who co-chairs the Roundtable on Science and Welfare in Laboratory Animal Use (which organized the workshop).
First, the researchers developed a
model of Parkinson's in zebrafish — the first
such animal
model of the
disease — and exposed them to ziram so that they lost dopamine.
«Computer
modeling, also known as in silico
modeling,
of such a complex
disease allows us to work toward potential treatments much more rapidly.»
«The
model also suggests ongoing warming
of global temperatures will likely influence the ecology and distribution
of such medically important ticks, favoring more tick - borne
diseases among people and pets.
While ADNI researchers use maps
such as these to study the pattern and range
of degeneration among groups
of patients over time, this
model could also be used to monitor the progress
of the
disease in a single patient.
With their experimental collaborators, the researchers are now exploring whether the algorithm can
model more complex biological processes,
such as the dynamics
of insulin secretion in the pancreas and its relationship to the onset
of a
disease like diabetes.
Now, the same groups have built more elaborate
models that paint a detailed picture
of how the British countryside was ravaged by the FMD virus, taking into account things
such as the location
of every farm, the estimated number
of pigs, cattle, and sheep each farm contained, as well as exhaustive data about the spread
of the
disease and the culling process.
«In the future,
such efforts could allow us to much better understand human - microbiome interactions,
model malnutrition disorders and inflammatory
diseases of the gut, and perform personalized drug testing,» said co-first author Alessio Tovaglieri, a Graduate Student at the Department
of Health Science and Technology at ETH Zurich in Switzerland, who performs his thesis work on Ingber's team.
His symptoms may come closer to mimicking the human
disease than most mouse
models of mental illness, because the gene involved has
such a powerful effect.
By tuning the
model to replicate population data,
such as the number
of people at risk for developing TB and the fraction
of TB patients who have drug resistance, the
model can predict changes in the TB
disease burden — or number
of cases — over many years.
Several other components would be disbursed among the National Institute
of General Medical Sciences (
such as
disease model resources), NIH's imaging institute, and its institute for minority health research.
That has implications for genetic
models that predict how likely it is that members
of a family will inherit a trait, whether it's a
disease such as schizophrenia or a physical trait,
such as height.
In a Philadelphia Inquirer op - ed, he wrote that
such eternal life was in our reach because «Being able to decode the human genome allows us to develop detailed
models of how major
diseases,
such as heart
disease and cancer, progress, and gives us the tools to reprogram those processes away from
disease.»
Such a language is a critical and essential element in addressing the ongoing challenge
of developing more intricate and comprehensive
models of Alzheimer's
disease... for the identification
of new interventions and diagnostics.»
The
model offers the possibility
of carrying out studies that might result in treatments to reverse or prevent
diseases such as type 2 diabetes and obesity.»
Besides potentially upending the textbook
model of DNA organization, the team's results suggest that controlling access to chromatin could be a useful approach to preventing, diagnosing and treating
diseases such as cancer.
A new
model for post-integration latency in macroglial cells to study HIV - 1 reservoirs
of the brain, AIDS, DOI: 10.1097 / QAD.0000000000000691 Link to the original publication As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal
of developing personalized medical approaches for the prevention and therapy
of major common
diseases such as diabetes mellitus and lung
diseases.
Experimental animal
models have been used to investigate many aspects
of the clinical
disease such as the sex bias in myocarditis where testosterones in males promote autoimmunity in the heart while estrogens in females suppress virus infection and autoimmunity.
«In the future,
such detailed digital
models of diseases and the structure
of organs could be used to help diagnose conditions, understand the impact
of surgical interventions and even run digital drug trials.
We postulate that HD mutant hPSC (embryonic or induced) lines can constitute
such models and would be key to the exploration
of the molecular mechanisms
of the
disease and ultimately allow the screening
of therapeutic compounds endowed with a therapeutic potential.
«We are excited to be part
of such a visionary initiative from the three leading ALS foundations to build a truly groundbreaking
model to underpin the future
of therapeutics discovery,» said Wen Hwa Lee, Ph.D., Director
of Disease Foundations at the Structural Genomics Consortium and based at the University
of Oxford.
Using this
model, individuals and public health officials can monitor
disease incidence and implement strategies —
such as vaccination campaigns, communicating to the public and allocating resources — to stay one step ahead
of infectious
disease spread.
The objective is to support innovative projects dedicated to the development and the study
of rare
disease models using small animals (mouse
model excepted)
such as zebrafish, drosophila, nematode, rat and rabbit.
These in turn can be used for
disease modeling and drug discovery, but hopefully one day also for cell - based therapy of the many devastating diseases such as Alzheimer and Parkinson's D
disease modeling and drug discovery, but hopefully one day also for cell - based therapy
of the many devastating
diseases such as Alzheimer and Parkinson's
DiseaseDisease.
Human embryonic stem cells derived from affected embryos during a pre-implantation diagnostic (PGD), as well as the conversion
of somatic cells,
such as skin fibroblasts, into induced pluripotent stem cells by genetic manipulation, offer the unique opportunity to have access to a large spectrum
of disease - specific cell
models.
We carry out translational research programmes to develop infectious
disease vaccines, therapeutics and diagnostics using animal
models of tuberculosis, influenza, HIV / AIDS, Clostridium difficile, meningococcal
disease, chlamydia, burkholderia and anthrax, as well as emerging viral
diseases such as Crimean Congo haemorrhagic fever.
Historically, researchers have generated their own lines
of knockout mice to serve as
models for human
disease,
such as heart
disease or cancer.
Complementing its extensive capabilities, PsychoGenics offers a variety
of validated mouse
models including in - licensed transgenic
models that support research in areas
such as Alzheimer's
disease, Huntington's
disease, Parkinson's
disease, Autism spectrum disorders, psychosis / schizophrenia, Spinal Muscular Atrophy (SMA), muscular dystrophy and other muscle disorders.
He uses the paradigm
of nuclear hormone receptor activation / signaling and the contribution
of this process to myeloid cell differentiation, function, and to
diseases, involving these cells,
such as atherosclerosis, tissue regeneration, metabolic, and various inflammatory disorders, as his
model systems.